Objectives The central nervous system is a significant extraglandular target in primary Sjögren’s syndrome (pSS), often ...

As of 2025, MAID is authorized in Oregon, Washington, Montana, Vermont, California, Colorado, Hawaii, New Jersey, Maine, New Mexico, Delaware, and the District of Columbia, collectively covering more ...